Navigation Links
Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
Date:2/1/2012

as: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Arena Pharmaceuticals® and Arena® are registered service marks of the company.

About Eisai Inc.Eisai Inc. was established in 1995 and is ranked among the top-25 US pharmaceutical companies (based on retail sales). The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business. Eisai's areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the US pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai has a global product creation organization that includes US-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina. The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com/us.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the advancement, therapeutic indication and use, safety, efficacy, mechanism of action, and potential of lorcaserin; the FDA's review of the lorcaserin NDA resubmission and the potential timing for the FDA to complete such review; the FDA advisory committee meeting and the discussion on the lorcaserin NDA resubmission; availability of information in the Federal Register; the potential approval and commercialization of lorcaserin; the Eisai collaboration and potential activities thereunder;

lorcaserin's patent cov
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 1, 2015 Ansell, a global ... winners of the first Ansell Cares ® ... Nurses. The 2015 award, organised in partnership with the ... who display exceptional skill and quality in patient care, ... development. Award ceremonies are taking place today in the ...
(Date:6/30/2015)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... today announced it has submitted its fifth abbreviated new ... Administration (FDA) of 2015, which brings the Company,s total ... to twenty-seven. Jason Grenfell-Gardner , President ... current pipeline of twenty-seven submissions, exclusive of our four ...
(Date:6/30/2015)... , June 30, 2015  A new report ... a campaign to promote public education and training opportunities ... and defibrillation. Annual rates of CPR ... percent in the United States ... cardiac arrest survival. The American Red Cross strongly supports ...
Breaking Medicine Technology:Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 3New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 4
... Carl Zeiss Group is adopting AT&T ... suppliers and subsidiaries around the world, across three continents. ... leader in the optical and optoelectronics industry with around ... countries Carl Zeiss will connect sites in Germany ...
... Health care costs are increasing, but NeedyMeds.org ... save money while staying healthy. NeedyMeds.org is ... discounts on prescription medications and other medical needs.  Consumer ... both English and Spanish regarding cost savings on prescription ...
Cached Medicine Technology:AT&T Helps Make The World a Smaller Place for Carl Zeiss 2AT&T Helps Make The World a Smaller Place for Carl Zeiss 3AT&T Helps Make The World a Smaller Place for Carl Zeiss 4Non-Profit Offers 3 Easy Consumer Tips to Save on Prescriptions 2
(Date:6/30/2015)... ... June 30, 2015 , ... The LIV Fertility Center in Puerto Vallarta ... the right age to pursue egg freezing. Statistics show that 20 percent of women ... a 150 percent increase since the 1970s. , Sadly, for women who have delayed ...
(Date:6/30/2015)... Grand Terrace, CA (PRWEB) , ... June 30, ... ... its Five-Star Medicare rating in a new video, “Grand Terrace Health Care Center.” ... keep facilities accountable and help patients find the best facility for their needs. ...
(Date:6/30/2015)... Port Richey, FL (PRWEB) , ... June 30, 2015 , ... ... use nearly doubled from 2007 to 2013 while heroin-related deaths more than tripled in ... greatest drug threat (1). Novus Medical Detox Center , a leading Florida-based drug ...
(Date:6/30/2015)... ... 2015 , ... ADVOCATE, the premier provider of radiology revenue ... billing agreements with Jackson Radiology Associates in Jackson, TN. , ADVOCATE ... billing process software functionality called Experience Based Technology (EBTTM). EBTTM improves radiology ...
(Date:6/30/2015)... ... June 30, 2015 , ... On June 26, 2015, Harper’s Bazaar ... five triggers that most people would not expect to cause acne flare-ups. ... primary causes of acne are clogged pores and bacteria and each of ...
Breaking Medicine News(10 mins):Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2
... , 70 Years of Service Excellence and Innovation Leads ... to Improve Patient Care and Increase Productivity , ... interoperability of disparate healthcare IT systems, announced today that ... Radiology Associates of the Fox Valley (RAFV) of Neenah, ...
... , CARLSBAD, Calif., June 5 Isis Pharmaceuticals, Inc. (Nasdaq: ... management will present a company overview at the 8th Annual Needham ... ET at the New York Palace Hotel. , ... on the "Investor Center" section of the Company,s Web site, ...
... ... London Clinic. The contract marks the world,s first live site of the company,s latest Rhapsody™ ... Auckland, ... workflow and integration technology for the health care sector world-wide, has signed a contract with ...
... ... to his distinguished career as attorney in Maryland , ... Columbia, Maryland (Lexis Nexis) -- Bruce Plaxen, founding ... as the 2008 Maryland Trial Lawyer of the Year by the non-profit Maryland Association ...
... They Would During Any Flu Outbreak , , HARRISBURG, Pa., ... Novel Influenza A/H1N1 was reported today in Berks County. Currently, the ... due to this virus. Nationally, there are 11,054 confirmed cases of ... this 55-year-old woman is a sad reminder of the complications that ...
... June 4 Today, in Los Angeles, Univision, People en Espanol, ... to the Latino community as la Doctora Aliza (TM), announced ... (TM). , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090604/SF28145 ) ... the largest source of health information and wellness tools in Spanish ...
Cached Medicine News:Health News:Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 2Health News:Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 3Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bruce Plaxen Named 2008 Maryland Trial Lawyer of the Year by Maryland Association for Justice 2Health News:Health Department Reports Pennsylvania's First Death Due to 2009 Novel Influenza A/H1N1 Virus 2Health News:Univision's Doctora Aliza Launches VidaySalud.com(TM) 2
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... Focus multichannel pipettes speed ... reagents into microplates, with ... l volumes. The improved ... Focus multichannels, combined with ...
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
Medicine Products: